Literature DB >> 26629033

MTSS1 gene regulated by miR-96 inhibits cell proliferation and metastasis in tongue squamous cellular carcinoma Tca8113 cell line.

Yan Guo1, Mei-Si Ren2, Chao Shang3, Li Zhu1, Ming Zhong4.   

Abstract

BACKGROUND: Metastasis suppressor-1 (MTSS1) is a novel potential metastasis suppressor gene in several types of human cancers. However, the exact function and regulatory mechanism of MTSS1 in Tongue squamous cellular carcinoma (TSCC) have not been elucidated. MATERIAL/
METHODS: We first confirmed the MTSS1 gene expression by using quantitative real time-PCR (qRT-PCR) and immunohistochemical staining. Then we detected the effect of MTSS1 gene on Tca8113 cells proliferation and invasion ability by using MTT, wound healing and invasion assay. Finally by using bioinformatics analysis, luciferase reporter assay and a serial method, we analyzed the targeting of miR-96 on MTSS1 and the ability of miR-96 on MTSS1 gene mediated biological alterations in Tca8113 cells.
RESULTS: Our findings showed that the expression of MTSS1 was down-regulated in both TSCC tissues and Tca8113 cells. Forced expression of MTSS1 led to inhibited cell proliferation ability, retarded wound closing and reduced trans-membrane cell numbers. MiR-96 is confirmed to be a direct target of MTSS1 gene and could regulate MTSS1 mediated Tca8113 cells proliferation and metastasis. But miR-96 could not completely restore the invasion ability of Tca8113 cells.
CONCLUSIONS: MiR-96 targeting and promoting MTSS1 repression may precipitate in the TSCC tumorigenesis through bypassing cell proliferation and metastasis control.

Entities:  

Keywords:  Cell proliferation; microRNAs; neoplasm metastasis; tongue cancer

Year:  2015        PMID: 26629033      PMCID: PMC4658922     

Source DB:  PubMed          Journal:  Int J Clin Exp Med        ISSN: 1940-5901


  24 in total

1.  Metastasis suppressor-1, MTSS1, acts as a putative tumour suppressor in human bladder cancer.

Authors:  Peng Du; Lin Ye; Fiona Ruge; Yong Yang; Wen G Jiang
Journal:  Anticancer Res       Date:  2011-10       Impact factor: 2.480

Review 2.  Epidemiology of oral cancer in Asia in the past decade--an update (2000-2012).

Authors:  Sree Vidya Krishna Rao; Gloria Mejia; Kaye Roberts-Thomson; Richard Logan
Journal:  Asian Pac J Cancer Prev       Date:  2013

3.  MIM-B, a putative metastasis suppressor protein, binds to actin and to protein tyrosine phosphatase delta.

Authors:  Jacquelyn A Woodings; Stewart J Sharp; Laura M Machesky
Journal:  Biochem J       Date:  2003-04-15       Impact factor: 3.857

4.  Suppression of MIM by microRNA-182 activates RhoA and promotes breast cancer metastasis.

Authors:  R Lei; J Tang; X Zhuang; R Deng; G Li; J Yu; Y Liang; J Xiao; H-Y Wang; Q Yang; G Hu
Journal:  Oncogene       Date:  2013-03-11       Impact factor: 9.867

5.  Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer.

Authors:  Christian Parr; Wen G Jiang
Journal:  Eur J Cancer       Date:  2009-03-26       Impact factor: 9.162

6.  MicroRNA-182 downregulates metastasis suppressor 1 and contributes to metastasis of hepatocellular carcinoma.

Authors:  Jian Wang; Jingwu Li; Junling Shen; Chen Wang; Lili Yang; Xinwei Zhang
Journal:  BMC Cancer       Date:  2012-06-08       Impact factor: 4.430

7.  miR-24 functions as a tumor suppressor in Hep2 laryngeal carcinoma cells partly through down-regulation of the S100A8 protein.

Authors:  Yan Guo; Weineng Fu; Hong Chen; Chao Shang; Ming Zhong
Journal:  Oncol Rep       Date:  2011-11-30       Impact factor: 3.906

8.  The impact of Metastasis Suppressor-1, MTSS1, on oesophageal squamous cell carcinoma and its clinical significance.

Authors:  Fei Xie; Lin Ye; Jinfeng Chen; Nan Wu; Zhiqian Zhang; Yue Yang; Lijian Zhang; Wen G Jiang
Journal:  J Transl Med       Date:  2011-06-22       Impact factor: 5.531

9.  SCF β-TRCP targets MTSS1 for ubiquitination-mediated destruction to regulate cancer cell proliferation and migration.

Authors:  Jiateng Zhong; Shavali Shaik; Lixin Wan; Adriana E Tron; Zhiwei Wang; Liankun Sun; Hiroyuki Inuzuka; Wenyi Wei
Journal:  Oncotarget       Date:  2013-12

10.  Whole genome expression profiling of blood cells in ovarian cancer patients -prognostic impact of the CYP1B1, MTSS1, NCALD, and NOP14.

Authors:  Helena S Isaksson; Bengt Sorbe; Torbjörn K Nilsson
Journal:  Oncotarget       Date:  2014-06-30
View more
  10 in total

1.  Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.

Authors:  Matthew D Taylor; Oana Bollt; Soumya C Iyer; Gavin P Robertson
Journal:  Clin Exp Metastasis       Date:  2017-12-07       Impact factor: 5.150

2.  Local microRNA delivery targets Palladin and prevents metastatic breast cancer.

Authors:  Avital Gilam; João Conde; Daphna Weissglas-Volkov; Nuria Oliva; Eitan Friedman; Natalie Artzi; Noam Shomron
Journal:  Nat Commun       Date:  2016-09-19       Impact factor: 14.919

3.  MiR-139-5p inhibits the tumorigenesis and progression of oral squamous carcinoma cells by targeting HOXA9.

Authors:  Kai Wang; Jun Jin; Tengxiao Ma; Hongfeng Zhai
Journal:  J Cell Mol Med       Date:  2017-08-05       Impact factor: 5.310

4.  Missing-in-metastasis B (MIM-B) combined with caveolin-1 promotes metastasis of hepatocellular carcinoma.

Authors:  Xiu-Yan Huang; Zi-Li Huang; Tao Niu; Zhen-Qian Wu; Bin Xu; Yong-Hua Xu; Xin-Yu Huang; Qi Zheng; Jian Zhou; Zi Chen; Zhao-You Tang
Journal:  Oncotarget       Date:  2017-09-08

5.  PTEN-Dependent Stabilization of MTSS1 Inhibits Metastatic Phenotype in Pancreatic Ductal Adenocarcinoma.

Authors:  Ann E Zeleniak; Wei Huang; Melissa L Fishel; Reginald Hill
Journal:  Neoplasia       Date:  2017-11-23       Impact factor: 5.715

Review 6.  Prospective applications of microRNAs in oral cancer.

Authors:  Chuan Fang; Yadong Li
Journal:  Oncol Lett       Date:  2019-08-16       Impact factor: 2.967

Review 7.  Gene expression changes contribute to stemness and therapy resistance of relapsed acute myeloid leukemia: roles of SOCS2, CALCRL, MTSS1, and KDM6A.

Authors:  Alexander M Grandits; Rotraud Wieser
Journal:  Exp Hematol       Date:  2021-05-21       Impact factor: 3.084

8.  Downregulation of MTSS1 in acute myeloid leukemia is associated with a poor prognosis, chemotherapy resistance, and disease aggressiveness.

Authors:  Gerwin Heller; Rotraud Wieser; Alexander Michael Grandits; Chi Huu Nguyen; Angela Schlerka; Hubert Hackl; Heinz Sill; Julia Etzler; Elizabeth Heyes; Dagmar Stoiber; Florian Grebien
Journal:  Leukemia       Date:  2021-03-29       Impact factor: 11.528

9.  miR-96 promotes breast cancer metastasis by suppressing MTSS1.

Authors:  Wei Xie; Feng Sun; Lin Chen; Xinjian Cao
Journal:  Oncol Lett       Date:  2018-01-04       Impact factor: 2.967

10.  LRP6 is identified as a potential prognostic marker for oral squamous cell carcinoma via MALDI-IMS.

Authors:  Yao Yuan; Xiaoyan Xie; Yuchen Jiang; Zihao Wei; Peiqi Wang; Fangman Chen; Xinyi Li; Chongkui Sun; Hang Zhao; Xin Zeng; Lu Jiang; Yu Zhou; Hongxia Dan; Mingye Feng; Rui Liu; Zhiyong Wang; Qianming Chen
Journal:  Cell Death Dis       Date:  2017-09-07       Impact factor: 8.469

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.